Home/Filings/4/0001209191-19-033525
4//SEC Filing

Maloberti Renaud Bertrand 4

Accession 0001209191-19-033525

CIK 0001681682other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 7:33 PM ET

Size

5.4 KB

Accession

0001209191-19-033525

Insider Transaction Report

Form 4
Period: 2019-05-28
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
  • Award

    Stock Options

    2019-05-28+35,00035,000 total
    Exercise: $1.04Exp: 2029-05-28Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]These Stock Options become exercisable in three equal annual installments beginning on May 28, 2020.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001744025

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 7:33 PM ET
Size
5.4 KB